Sign In
Buy MNKD
$3.36
-0.0700 (-2.04%)
At Close: Jun 03, 2026
MannKind: December MidCap Requirement And Afrezza Losses
12:00am, Thursday, 12'th Dec 2019MannKind: New Loan Structure Leads To Financial Uncertainty
12:00am, Wednesday, 04'th Dec 2019MannKind Corporation to Present at the Piper Jaffray '–st Annual Healthcare Conference
12:00am, Friday, 29'th Nov 2019MannKind Adds New Board Member - What It Means To Investors And Investor Activists
12:00am, Friday, 22'nd Nov 2019MannKind Corporation 2019 Q3 - Results - Earnings Call Presentation
12:00am, Wednesday, 13'th Nov 2019Teva Q3 profit misses estimates, tightens FY19 forecast | AlphaStreet
12:14pm, Thursday, 07'th Nov 2019
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) reported a wider loss in the third quarter of 2019. The bottom line missed analysts' expectations.
